Upon treatment with a GSK-3β inhibitor, ASK1 levels were not recovered if the USP9X gene was silenced, implying the critical role of USP9X in stabilizing ASK1 in HCC [71]. This evidence concerns the gene MAP3K5 and hepatocellular carcinoma.